Appointment of CEO/Managing Director
Filed with ASX · · 3 pages · English
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings CallEarlier from Impedimed
- FY26 Half Year Financial Results
- Appendix 4D and Interim Financial Report
- ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors
- Quarterly Activities Report and Appendix 4C - Dec-2025
- Quarterly Activities Report and Appendix 4C - Sep-2025 Qtr
Later from Impedimed
- ImpediMed Appoints Erik Anderson as Chief Executive Officer
- Quarterly Activities Report and Appendix 4C - Mar-2026 Qtr
- ImpediMed announces a successful $15.2 million Capital Raise
- Equity Raising Investor Presentation
- CEO Business Update
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed